Home / Biotechnology / HIV/AIDS D

HIV/AIDS Diagnostics Market By Product Type (Antibody Tests, Hiv-1 Antibody Confirmatory Tests, Viral Identification Testing, Hiv-2 & Group O Diagnostics Tests, Viral Load Tests, Cd4 Testing, Early Infant Diagnosticss) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024

According to WHO study, until now around 70 million people are infected with HIV virus and 35 million died of HIV infection. With rising mortality, the government and non-government institutes are taking initiatives and providing funding for diagnostic treatment and prevention of HIV/AIDS. With  advancement of technology, novel diagnostic product are available in market which required minimum technical skills such as portable cell counter and point of care rapid diagnostic tests that fasten the diagnosis process. In developing countries such as India and China with growing population, rising awareness about HIV and emerging economies will be lucrative market for HIV/AIDS diagnostics. Increase in incidence of HIV infection, awareness about HIV/AIDs diagnosis and treatment, rising research and development for early diagnosis, treatment and prevention are key the factors driving the HIV/AIDS diagnostic market. 

The report titled “HIV/AIDS Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall HIV/AIDS diagnostics market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of multiple market segments based on type of product and different geographies. The product type segment studied for analyzing the overall global HIV/AIDS diagnostics market is majorly segmented into antibody test, HIV-2 & Group O diagnostic Tests, viral load tests, CD4 testing, early infant diagnostics, viral identification testing.

Geographically, the global HIV/AIDS diagnostics market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Mexico
    • Brazil
    • Rest of LATAM
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • South Africa
    • Rest of MEA

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2016-2024 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global HIV/AIDS diagnostics market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global HIV/AIDS diagnostics market. This report concludes with company profiles section that highlights major information about the key players engaged in global HIV/AIDS diagnostics market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.

HIV/AIDS Diagnostics Market

For the purpose of this study, the global HIV/AIDS diagnostics market is geographically categorized into:

  • North America (U.S. & Canada)
  • Europe (U.K., Germany & Rest of Europe)
  • Asia Pacific (China, Japan, and Rest of APAC)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East and Africa (UAE, Saudi Arabia, South Africa, Rest of Middle East and Africa)

HIV/AIDS Diagnostics Market

In 2016, North America dominated the global HIV/AIDS diagnostics market followed by the Europe. In North America region, U.S. occupies the maximum share of the market due to rise in prevalence of HIV infection, growing awareness programs and health care access, national funding for HIV affected people. Canada at regional level has different programs laid for treatment of AIDS, which further drives the diagnostic market in the country. Europe is the next important market driven by factors such as convenient access to health care facilities, high healthcare spending and introduction of novel treatment opportunities. Asia Pacific is anticipated to be fastest growing in HIV/AIDS diagnostic market in the forecast period. Developing countries contribute to rising number of HIV-AIDS population, and along with increase in government initiative for HIV diagnostic and treatment facilities, rising healthcare expenditure further drives the diagnostic market for Asia pacific.

Choose License Type
Published Date:  Jun 2017
Category:  Biotechnology
Report ID:   58512
Report Format:   PDF
Pages:   120
Rating:    4.3 (55)
Connect With Us
+1-408-641-3282
24/7 Research Support